149 related articles for article (PubMed ID: 27500791)
1. Highlights From the American Association of Pharmaceutical Scientists/ International Transporter Consortium Joint Workshop on Drug Transporters in Absorption, Distribution, Metabolism, and Excretion: From the Bench to the Bedside - Clinical Pharmacology Considerations.
Ronaldson PT; Bauer B; El-Kattan AF; Shen H; Salphati L; Louie SW
Clin Pharmacol Ther; 2016 Nov; 100(5):419-422. PubMed ID: 27500791
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.
Shitara Y; Maeda K; Ikejiri K; Yoshida K; Horie T; Sugiyama Y
Biopharm Drug Dispos; 2013 Jan; 34(1):45-78. PubMed ID: 23115084
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Proposed In Vivo Probe Substrates and Inhibitors for Phenotyping Transporter Activity in Humans.
Momper JD; Tsunoda SM; Ma JD
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S82-98. PubMed ID: 27385182
[TBL] [Abstract][Full Text] [Related]
4. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of membrane transporters: a review of current approaches.
Sissung TM; Goey AK; Ley AM; Strope JD; Figg WD
Methods Mol Biol; 2014; 1175():91-120. PubMed ID: 25150868
[TBL] [Abstract][Full Text] [Related]
6. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans.
Yamashiro W; Maeda K; Hirouchi M; Adachi Y; Hu Z; Sugiyama Y
Drug Metab Dispos; 2006 Jul; 34(7):1247-54. PubMed ID: 16624871
[TBL] [Abstract][Full Text] [Related]
7. Interindividual and Regional Variability in Drug Transporter Abundance at the Human Blood-Brain Barrier Measured by Quantitative Targeted Proteomics.
Billington S; Salphati L; Hop CECA; Chu X; Evers R; Burdette D; Rowbottom C; Lai Y; Xiao G; Humphreys WG; Nguyen TB; Prasad B; Unadkat JD
Clin Pharmacol Ther; 2019 Jul; 106(1):228-237. PubMed ID: 30673124
[TBL] [Abstract][Full Text] [Related]
8. Blood-Brain Barrier Transporters: Opportunities for Therapeutic Development in Ischemic Stroke.
Nilles KL; Williams EI; Betterton RD; Davis TP; Ronaldson PT
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163820
[TBL] [Abstract][Full Text] [Related]
9. EUFEPS conference on drug transporters at Copenhagen: integrative approaches in ADME research.
Meijer DK; Lennernäs H
Eur J Pharm Sci; 2005 Sep; 26(1):130-43. PubMed ID: 16161216
[No Abstract] [Full Text] [Related]
10. Sex-specific differences in organic anion transporting polypeptide 1a4 (Oatp1a4) functional expression at the blood-brain barrier in Sprague-Dawley rats.
Brzica H; Abdullahi W; Reilly BG; Ronaldson PT
Fluids Barriers CNS; 2018 Sep; 15(1):25. PubMed ID: 30208928
[TBL] [Abstract][Full Text] [Related]
11. Increased Expression of Renal Drug Transporters in a Mouse Model of Familial Alzheimer's Disease.
Pan Y; Omori K; Ali I; Tachikawa M; Terasaki T; Brouwer KLR; Nicolazzo JA
J Pharm Sci; 2019 Jul; 108(7):2484-2489. PubMed ID: 30825461
[TBL] [Abstract][Full Text] [Related]
12. Expression of thyroid hormone transporters and deiodinases at the brain barriers in the embryonic chicken: Insights into the regulation of thyroid hormone availability during neurodevelopment.
Van Herck SL; Delbaere J; Bourgeois NM; McAllan BM; Richardson SJ; Darras VM
Gen Comp Endocrinol; 2015 Apr; 214():30-9. PubMed ID: 25745816
[TBL] [Abstract][Full Text] [Related]
13. Transporters as a determinant of drug clearance and tissue distribution.
Shitara Y; Horie T; Sugiyama Y
Eur J Pharm Sci; 2006 Apr; 27(5):425-46. PubMed ID: 16488580
[TBL] [Abstract][Full Text] [Related]
14. Mouse reduced in osteosclerosis transporter functions as an organic anion transporter 3 and is localized at abluminal membrane of blood-brain barrier.
Ohtsuki S; Kikkawa T; Mori S; Hori S; Takanaga H; Otagiri M; Terasaki T
J Pharmacol Exp Ther; 2004 Jun; 309(3):1273-81. PubMed ID: 14762099
[TBL] [Abstract][Full Text] [Related]
15. [Effect of genetic polymorphism on the activity of drug transporters and its clinical significance].
Zhang HX; Wang LS
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 33(8):765-9. PubMed ID: 18772522
[TBL] [Abstract][Full Text] [Related]
16. Expression of the thyroid hormone transporters monocarboxylate transporter-8 (SLC16A2) and organic ion transporter-14 (SLCO1C1) at the blood-brain barrier.
Roberts LM; Woodford K; Zhou M; Black DS; Haggerty JE; Tate EH; Grindstaff KK; Mengesha W; Raman C; Zerangue N
Endocrinology; 2008 Dec; 149(12):6251-61. PubMed ID: 18687783
[TBL] [Abstract][Full Text] [Related]
17. Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes.
De Bruyn T; Ye ZW; Peeters A; Sahi J; Baes M; Augustijns PF; Annaert PP
Eur J Pharm Sci; 2011 Jul; 43(4):297-307. PubMed ID: 21605667
[TBL] [Abstract][Full Text] [Related]
18. Solute Carrier Family of the Organic Anion-Transporting Polypeptides 1A2- Madin-Darby Canine Kidney II: A Promising In Vitro System to Understand the Role of Organic Anion-Transporting Polypeptide 1A2 in Blood-Brain Barrier Drug Penetration.
Liu H; Yu N; Lu S; Ito S; Zhang X; Prasad B; He E; Lu X; Li Y; Wang F; Xu H; An G; Unadkat JD; Kusuhara H; Sugiyama Y; Sahi J
Drug Metab Dispos; 2015 Jul; 43(7):1008-18. PubMed ID: 25908246
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Organic Anion Transporter 1A2-knock-in Mice as a Model of Human Blood-brain Barrier.
Sano Y; Mizuno T; Mochizuki T; Uchida Y; Umetsu M; Terasaki T; Kusuhara H
Drug Metab Dispos; 2018 Nov; 46(11):1767-1775. PubMed ID: 30154106
[TBL] [Abstract][Full Text] [Related]
20. Membrane transporter proteins: a challenge for CNS drug development.
Girardin F
Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
